LBA104 First safety and efficacy results of the TAR-210 erdafitinib (erda) intravesical delivery system in patients (pts) with non–muscle-invasive bladder cancer (NMIBC) with select FGFR alterations (alt)

Antoni Vilaseca, Gautam Jayram, Carles X. Raventós, Neal D. Shore, Daniel Zainfeld, Taek Won Kang, Ja Hyeon Ku, Joshua J. Meeks, Ó. Rodríguez Faba, Florian Roghmann, Siamak Daneshmand, Neil Beeharry, Carrye Cost, Anna Kalota, Josh Lauring, M. Peterson, Michelle Quiroz, Nicole L. Stone, Wei Zhu, Félix Guerrero‐Ramos